Reduction of ??-Endorphin-Containing Immune Cells in Inflamed Paw Tissue Corresponds with a Reduction in Immune-Derived Antinociception: Reversible by Donor Activated Lymphocytes
- 1 March 2004
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 98 (3) , 723-729
- https://doi.org/10.1213/01.ane.0000099369.23397.d7
Abstract
The functional integrity of the immune system is essential for peripheral antinociception. Previous studies have demonstrated that immune cells elicit potent antinociception in inflamed tissues and that corticotropin-releasing factor-induced antinociception is significantly inhibited in animals that have undergone cyclosporin A (CsA)-induced immunosuppression. In this study, we examined the effect of a single bolus of CsA on inflammatory nociception. CsA-treated rats had substantially increased nociception compared with nonimmunosuppressed rats, consistent with a reduction in circulating and infiltrating lymphocytes. Furthermore, CsA-treated rats had inhibition of corticotropin-releasing factor-induced immune-derived antinociception, which was dose-dependently reversed by IV injection of concanavalin A-activated donor lymphocytes (1.0–7.0 × 106 cells/0.1 mL). In conclusion, our findings provided further evidence that opioid-containing immune cells are essential for peripheral analgesia. It is evident from these findings that control of inflammatory pain relies heavily on a functioning immune system.Keywords
This publication has 23 references indexed in Scilit:
- Methionine-enkephalin-and Dynorphin A-release from immune cells and control of inflammatory painPain, 2001
- Opioid Peptide–expressing LeukocytesAnesthesiology, 2001
- Annual Scientific Meeting of ASCEPT, 1999 Immune‐Derived Opioids And Peripheral AntinociceptionClinical and Experimental Pharmacology and Physiology, 2001
- Peripheral opioid analgesiaCurrent Opinion in Pharmacology, 2001
- Pain control in inflammation governed by selectinsNature Medicine, 1998
- Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats.Journal of Clinical Investigation, 1997
- Corticotropin-releasing factor in antinociception and inflammationEuropean Journal of Pharmacology, 1997
- Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue.Proceedings of the National Academy of Sciences, 1994
- Peripheral mechanisms of opioid antinociception in inflammation: involvement of cytokinesEuropean Journal of Pharmacology, 1993
- Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation.Proceedings of the National Academy of Sciences, 1990